# EDGEWELL PERSONAL CARE Co: overview

EPC · NYSE · CIK 1096752 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/epc.md) · [Financials](/companies/epc/financials.md) · [Filings](/companies/epc/filings.md) · [Insiders](/companies/epc/insiders.md)

Latest reported revenue: [$570.1m](/filings/0001628280-26-053128.md) for Q3 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 5, 2026 (XBRL us-gaap:Revenues, accession 0001628280-26-053128).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [518 d](/filings/0001628280-25-052765.md) | [415](/filings/0001628280-26-006288.md) | [517](/filings/0001628280-26-031376.md) | [560](/filings/0001628280-26-053128.md) | [731 d](/filings/0001628280-25-052765.md) | [423](/filings/0001628280-26-006288.md) | [520](/filings/0001628280-26-031376.md) | [570](/filings/0001628280-26-053128.md) |
| Gross margin | % | [41.1% d](/filings/0001628280-25-052765.md) | [41.6%](/filings/0001628280-26-006288.md) | [45.9%](/filings/0001628280-26-031376.md) | [44.6%](/filings/0001628280-26-053128.md) | [36.3% d](/filings/0001628280-25-052765.md) | [38.1%](/filings/0001628280-26-006288.md) | [41.8%](/filings/0001628280-26-031376.md) | [42.5%](/filings/0001628280-26-053128.md) |
| Operating margin | % | [3.9% d](/filings/0001628280-25-052765.md) | [2.2%](/filings/0001628280-26-006288.md) | [9.5%](/filings/0001628280-26-031376.md) | [8.0%](/filings/0001628280-26-053128.md) | [(0.9%) d](/filings/0001628280-25-052765.md) | [(4.5%)](/filings/0001628280-26-006288.md) | [3.5%](/filings/0001628280-26-031376.md) | [4.4%](/filings/0001628280-26-053128.md) |
| Net margin | % | [1.7% d](/filings/0001628280-25-052765.md) | [(0.5%)](/filings/0001628280-26-053128.md) | [5.6%](/filings/0001628280-26-053128.md) | [5.2%](/filings/0001628280-26-053128.md) | [(4.2%) d](/filings/0001628280-25-052765.md) | [(15.5%)](/filings/0001628280-26-053128.md) | [(2.0%)](/filings/0001628280-26-053128.md) | [2.4%](/filings/0001628280-26-053128.md) |
| Diluted EPS | $ per share | not reported | [(0.04)](/filings/0001628280-26-006288.md) | [0.60](/filings/0001628280-26-031376.md) | [0.62](/filings/0001628280-26-053128.md) | not reported | [(1.41)](/filings/0001628280-26-006288.md) | [(0.22)](/filings/0001628280-26-031376.md) | [0.29](/filings/0001628280-26-053128.md) |
| Free cash flow | $m | [(414) d](/filings/0001628280-25-052765.md) | [(132)](/filings/0001628280-26-006288.md) | [28.0 d](/filings/0001628280-26-031376.md) | [99.3 d](/filings/0001628280-26-053128.md) | [46.5 d](/filings/0001628280-25-052765.md) | [(138)](/filings/0001628280-26-006288.md) | [40.3 d](/filings/0001628280-26-031376.md) | [103 d](/filings/0001628280-26-053128.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-09-30) | FY2022 (2022-09-30) | FY2023 (2023-09-30) | FY2024 (2024-09-30) | FY2025 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,087](/filings/0001628280-23-040139.md) | [2,172](/filings/0001628280-24-047916.md) | [2,252](/filings/0001628280-25-052765.md) | [2,254](/filings/0001628280-25-052765.md) | [2,224](/filings/0001628280-25-052765.md) |
| Gross margin | % | [45.6%](/filings/0001628280-23-040139.md) | [40.5%](/filings/0001628280-24-047916.md) | [41.8%](/filings/0001628280-25-052765.md) | [42.4%](/filings/0001628280-25-052765.md) | [41.6%](/filings/0001628280-25-052765.md) |
| Operating margin | % | [11.5%](/filings/0001628280-23-040139.md) | [8.4%](/filings/0001628280-24-047916.md) | [10.1%](/filings/0001628280-25-052765.md) | [8.8%](/filings/0001628280-25-052765.md) | [4.3%](/filings/0001628280-25-052765.md) |
| Net margin | % | [5.6%](/filings/0001628280-23-040139.md) | [4.6%](/filings/0001628280-24-047916.md) | [5.1%](/filings/0001628280-25-052765.md) | [4.4%](/filings/0001628280-25-052765.md) | [1.1%](/filings/0001628280-25-052765.md) |
| Diluted EPS | $ per share | [2.13](/filings/0001628280-23-040139.md) | [1.85](/filings/0001628280-24-047916.md) | [2.21](/filings/0001628280-25-052765.md) | [1.97](/filings/0001628280-25-052765.md) | [0.53](/filings/0001628280-25-052765.md) |
| Free cash flow | $m | [172](/filings/0001628280-23-040139.md) | [45.6](/filings/0001628280-24-047916.md) | [(266)](/filings/0001628280-25-052765.md) | [(288)](/filings/0001628280-25-052765.md) | [41.4](/filings/0001628280-25-052765.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/epc/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $197.5m | 7,354,533 |  | Reduced −7,452 |
| [BRANDES INVESTMENT PARTNERS, LP](/funds/1015079.md) | 2026-06-30 | $189.6m | 7,059,831 |  | Added +338,754 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $145.2m | 5,406,848 |  | Added +1,162,423 |
| [Rubric Capital Management LP](/funds/1687509.md) | 2026-06-30 | $95.2m | 3,544,465 |  | Reduced −455,535 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $82.1m | 3,054,925 |  | Added +126,556 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $54.9m | 2,043,145 |  | Added +5,750 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $50.0m | 1,852,824 |  | Added +86,574 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $49.9m | 1,856,415 |  | Reduced −584,428 |
| [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $39.7m | 1,476,356 |  | Added +260,364 |
| [Woodline Partners LP](/funds/1784547.md) | 2026-06-30 | $32.5m | 1,209,328 |  | Added +509,936 |

## Recent filings

[All 1,641 filings](/companies/epc/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-23 | 08:15 ET | [8-K](/filings/0001628280-26-063147.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-063147 |
| 2026-08-05 | 13:38 ET | [10-Q](/filings/0001628280-26-053128.md) | Quarterly report, period 2026-06-30 | 0001628280-26-053128 |
| 2026-08-05 | 06:10 ET | [8-K](/filings/0001628280-26-052881.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-052881 |
| 2026-05-26 | 13:19 ET | [8-K](/filings/0001628280-26-037995.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-037995 |
| 2026-05-06 | 16:40 ET | [10-Q](/filings/0001628280-26-031376.md) | Quarterly report, period 2026-03-31 | 0001628280-26-031376 |
| 2026-05-06 | 06:14 ET | [8-K](/filings/0001628280-26-030870.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-030870 |
| 2026-02-09 | 13:35 ET | [10-Q](/filings/0001628280-26-006288.md) | Quarterly report, period 2025-12-31 | 0001628280-26-006288 |
| 2026-02-09 | 06:34 ET | [8-K](/filings/0001628280-26-006183.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-006183 |
| 2026-02-06 | 16:11 ET | [8-K](/filings/0001628280-26-006076.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-006076 |
| 2025-12-22 | 10:18 ET | [DEF 14A](/filings/0001104659-25-123567.md) | Proxy statement, period 2026-02-05 | 0001104659-25-123567 |

## Latest annual report

[Form 10-K for the fiscal year ended Sep 30, 2025](/filings/0001628280-25-052765.md), filed Nov 18, 2025.

## Forecast league

Q4 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/ac442571-a9fc-45b9-9c9d-f44b2310968b)

## About the filer

- CIK: 1096752
- Tickers: EPC
- Exchange: NYSE
- SIC code: 2844 Perfumes, Cosmetics & Other Toilet Preparations
- State of incorporation: MO
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.